RegMol · The most advanced HELM implementation to support every therapeutic modality including ADCs, peptides, oligonucleotides and small molecules. · See how it works ↗
Client Help Center
Request A Demo

RegMol

RegMol is a comprehensive entity registration and testing protocol management system that supports a broad range of therapeutic modalities, including small molecules, peptides, oligonucleotides, antibodies, and antibody-drug conjugates (ADCs). Designed to enable data-driven decision-making, RegMol provides powerful data mining and analytics capabilities, allowing researchers to search and analyze information by chemical structure, HELM notation, and biological sequence. By centralizing registration, protocol management, and advanced search capabilities, RegMol helps research teams improve data quality, streamline workflows, and accelerate scientific discovery.

Request A Demo
Download the Brochure

Standardization

Register and Manage All Drug Modalities on a Single Platform

Managing different therapeutic modalities across multiple systems is both costly and inefficient. RegMol provides a unified platform for registering and managing a broad range of therapeutic modalities, including small molecules, peptides, oligonucleotides, antibodies, and antibody-drug conjugates (ADCs). RegMol’s advanced Conjugate Builder technology enables scientists to design, register, and manage a diverse array of drug conjugates, including antibody-drug conjugates (ADCs), degrader-antibody conjugates (DACs), antibody-oligonucleotide conjugates (AOCs), peptide-oligonucleotide conjugates (POCs), and antibody-radionuclide conjugates. By supporting multiple modalities and complex conjugates within a single, integrated platform, RegMol streamlines R&D workflows, improves data consistency, and accelerates therapeutic discovery and development. 

Insight

Register Testing Protocols and Manage Associated Data

A molecule registration database delivers limited value without the testing data that validates and characterizes each entity. RegMol addresses this challenge by providing a comprehensive platform for registering and managing testing protocols, including bioassays, CMC procedures, and other experimental workflows. Testing results are seamlessly linked to the corresponding protocols and registered molecules, creating a centralized, searchable R&D knowledge base. This integrated approach enables scientists to analyze data in context, improve collaboration, and make faster, data-driven decisions throughout the drug discovery and development process. 

Unified Informatics Platform for All Therapeutics Modalities

Our Proprietary Sketching Tools Included in All Our Solutions

Scilligence’s developer toolkits (JSDraw, MolEngine and MolSQL) is the foundation of a unified informatics platform for all therapeutic modalities, leveraging the industry’s most advanced HELM implementation to support small molecules, peptides, oligonucleotides, antibodies, and drug conjugates. Built-in cheminformatics and bioinformatics capabilities empower scientists throughout the entire R&D lifecycle, from early discovery to late-stage development. 

Request A Demo

Empower Your Team

Today is the day to equip your R&D team with the state-of-the-art informatics technology.

Request A Demo
Scroll to Top